Infinite Biomedical Technologies
9
3
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Sonomyographic Upper Limb Prosthetics: A New Paradigm
Role: collaborator
Long-Term Stability of the Glide Control Strategy
Role: lead
Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss
Role: lead
To Evaluate the Clinical Impact of the Point Powered System
Role: collaborator
Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses
Role: lead
RESCU System for Robust Upper Limb Prosthesis Control
Role: lead
A Patient-Driven Augmented Reality-Based Rehabilitation System to Improve Upper Limb Amputee Outcomes
Role: lead
Enhancing Upper Limb Prostheses With Radio Frequency Identification
Role: lead
Cardiac Arrest Recovery EEG Study
Role: lead
All 9 trials loaded